| Literature DB >> 29628916 |
Leonardo N Andrade1, Thiago E S Siqueira2, Roberto Martinez2, Ana Lucia C Darini1.
Abstract
Bacterial resistance to antibiotics is concern in healthcare-associated infections. On the other hand, bacterial tolerance to other antimicrobials, like heavy metals, has been neglected and underestimated in hospital pathogens. Silver has long been used as an antimicrobial agent and it seems to be an important indicator of heavy metal tolerance. To explore this perspective, we searched for the presence of acquired silver resistance genes (sil operon: silE, silS, silR, silC, silF, silB, silA, and silP) and acquired extended-spectrum cephalosporin and carbapenem resistance genes (blaCTX-M and blaKPC) in Enterobacter cloacae Complex (EcC) (n = 27) and Enterobacter aerogenes (n = 8) isolated from inpatients at a general hospital. Moreover, the genetic background of the silA (silver-efflux pump) and the presence of other acquired heavy metal tolerance genes, pcoD (copper-efflux pump), arsB (arsenite-efflux pump), terF (tellurite resistance protein), and merA (mercuric reductase) were also investigated. Outstandingly, 21/27 (78%) EcC isolates harbored silA gene located in the chromosome. Complete sil operon was found in 19/21 silA-positive EcC isolates. Interestingly, 8/20 (40%) E. hormaechei and 5/6 (83%) E. asburiae co-harbored silA/pcoD genes and blaCTX-M-(15,2,or9) and/or blaKPC-2 genes. Frequent occurrences of arsB, terF, and merA genes were detected, especially in silA/pcoD-positive, multidrug-resistant (MDR) and/or CTX-M-producing isolates. Our study showed co-presence of antibiotic and heavy metal tolerance genes in MDR EcC isolates. In our viewpoint, there are few studies regarding to bacterial heavy metal tolerance and we call attention for more investigations and discussion about this issue in different hospital pathogens.Entities:
Keywords: ESBL; Enterobacter cloacae complex species; carbapenemase; copper; silver
Year: 2018 PMID: 29628916 PMCID: PMC5876308 DOI: 10.3389/fmicb.2018.00539
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
Heavy metal resistance genes, bla genes, and antibiotic-resistance phenotypes of the Enterobacter spp. isolates studied.
| E06 | – | – | – | ||
| E11 | CTX-M-9 | TZP, CTX, CAZ | – | ||
| E20 | CTX-M-9 | TZP, CTX, CAZ, IPM | MDR | ||
| E17 | CTX-M-9 | TZP, CTX, CAZ, FEP, IPM, MER, GEN | MDR | ||
| E46 | CTX-M-9, KPC-2 | TZP, CTX, CAZ, FEP, ERT, IMP, MER, NAL, SXT, GEN, NIT | MDR | ||
| E43 | CTX-M-15 | CTX, STX, GEN, NIT | MDR | ||
| E21 | CTX-M-15 | TZP, CTX, CAZ, FEP, CIP, TGC | MDR | ||
| E22 | CTX-M-15 | TZP, CTX, CAZ, FEP, ERT, CIP, GEN, TGC | MDR | ||
| E42 | CTX-M-15 | TZP, CTX, FEP, NAL, NOR, CIP, STX, GEN, NIT | MDR | ||
| E44 | CTX-M-15 | CTX, STX, GEN, NIT | MDR | ||
| E40 | CTX-M-15 | TZP, CTX, ERT, MER, NAL, NOR, CIP, STX, GEN, NIT | MDR | ||
| E50 | CTX-M-15 | CTX, CAZ, FEP, GEN | - | ||
| E49 | CTX-M-2 | TZP, CTX, CAZ, FEP, CIP, GEN | MDR | ||
| E31 | KPC-2 | TZP, CTX, CAZ, FEP, ERT, IPM, MER, NAL, NOR, CIP, TGC, NIT | MDR | ||
| E08 | – | – | – | ||
| E09 | – | – | – | ||
| E12 | – | – | – | ||
| E13 | – | – | – | ||
| E47 | – | – | – | ||
| E19 | – | TZP, CTX, CAZ | – | ||
| E07 | – | – | TZP, CTX, CAZ | – | |
| E04 | – | NIT | – | ||
| E03 | – | – | NAL, NOR, CIP, STX, NIT | – | |
| E10 | – | – | NIT | – | |
| E15 | – | – | - | – | |
| E51 | – | – | - | – | |
| E48 | – | - | – | ||
| E01 | – | – | NIT | – | |
| E02 | – | – | NIT | – | |
| E05 | – | – | TZP, NIT | – | |
| E14 | – | – | - | – | |
| E23 | – | – | NIT | – | |
| E29 | – | – | - | – | |
| E39 | – | – | - | – | |
| E41 | – | – | NIT | – |
E. asburiae E11 and E17 isolates belonged to same pulsotype. The other EcC isolates and E. aerogenes isolates corresponded to different pulsotypes; E. hormaechei E07 and E19 isolates displayed cefotaxime and ceftazidime resistance due to overproducing AmpC (ESBL negative) (data not shown).
Piperacillin-tazobactam (TZP), cefotaxime (CTX), ceftazidime (CAZ), cefepime (FEP), ertapenem (ERT), imipenem (IPM), meropenem (MER), ertapenem (ERT), gentamicin (GEN), nitrofurantoin (NIT), nalidixic acid (NAL), norfloxacin (NOR), ciprofloxacin (CIP), trimethoprim-sulfamethoxazole (SXT), tigecycline (TGC).
MDR, multidrug-resistance (Magiorakos et al., .